Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities
Abstract Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility.Clinical features of POF are hypoestrogenism or estrogen deficiency, Artificial Flowers increased gonadotropin level, and, most importantly, amenorrhea.With the development of regenerative medicine, human mesenchymal stem cell (hM